A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects

NCT04154501 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Centrexion Therapeutics